Evaluation of the effectiveness and safety of interferon alpha-2b ointment and gel for prevention of acute respiratory infections in organized groups

Evaluation of the effectiveness and safety of interferon alpha-2b ointment and gel for prevention of acute respiratory infections in organized groups

Relevance: the annual incidence of acute respiratory infections (ARI) is in the lead in the structure of infectious pathology in the Russian Federation. One of the main issues is the development of optimal strategies for prevention of these diseases in high-risk groups.Aim: to evaluate the preventiv...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. V. Kozlov, K. V. Zhdanov, O. V. Maltsev, K. Kasyanenko, A. S. Sigidaev, Yu. I. Lyashenko, S. S. Kozlov, S. N. Sidorchuk, A. V. Saulevich, V. S. Sukachev
Format:	Article
Language:	Russian
Published:	Journal Infectology 2024-04-01
Series:	Журнал инфектологии
Subjects:	interferon alpha-2b interferons acute respiratory infections prevention
Online Access:	https://journal.niidi.ru/jofin/article/view/1606
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interferons alpha and gamma, pidotimod, and tilorone in the treatment of acute respiratory infections in patients with allergic rhinitis: a prospective, cohort clinical and immunological study
by: O. V. Kalyuzhin, et al.
Published: (2022-07-01)

Interferon Status and Choice of Interferons Inducers in Frequently Ill Children
by: M. S. Savenkovа, et al.
Published: (2016-06-01)

Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
by: Kata Ferenczi, et al.
Published: (2025-05-01)

Еxternal forms of recombinant interferon alfa-2b - ointment and gel in the treatment of acute respiratory viral infections and influenza in children
by: O. V. Shamsheva, et al.
Published: (2020-06-01)

IMMUNOPATHOGENESIS OF ACUTE RESPIRATORY INFECTIONS AND TACTICS OF RATIONAL CHOICE OF ETIOTROPIC IMMUNOMODULATORY THERAPIES IN CHILDREN
by: V. V. Malinovskaya, et al.
Published: (2015-08-01)

Interferon alpha-induced reduction in the values of myeloid-derived suppressor cells in melanoma patients
by: Stanojević Ivan, et al.
Published: (2015-01-01)

The Value of the Interferon Inductors in the Treatment and Prevention of Respiratory Infections
by: O. V. Kladova, et al.
Published: (2016-11-01)

DEVELOPMENT AND VALIDATION OF IMMUNOASSAY FOR IMMUNOGENICITY OF INTERFERON-ALPHA 2A DRUGS
by: E. V. Mityushova, et al.
Published: (2019-01-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
by: Maria Dimou, et al.
Published: (2014-01-01)

The effectiveness of Interferon-Ophthalmo, an antiviral and immunotropic drug, in the treatment of adenoviral ophthalmic infections
by: E. V. Yani, et al.
Published: (2023-03-01)

Universal approaches to the treatment of acute respiratory viral infection and influenza
by: A. V. Mordyk, et al.
Published: (2023-08-01)

Evolution of antiviral treatment chronic for hepatitis B, C and D
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

ADMINISTRATION CRITERIA FOR INTERFERON-BASED DRUGS AND ITS INDUCERS IN ACUTE RESPIRATORY INFECTIONS IN CHILDREN
by: E. G. Golovacheva, et al.
Published: (2014-07-01)

Evaluation of the effectiveness of antiviral therapy for coronavirus infection (COVID-19) with the inclusion of recombinant interferon alpha-2b
by: A. V. Mordyk, et al.
Published: (2022-10-01)

Effects of Treatment with Temsirolimus versus Interferon Alpha on Survival of Patients with Metastatic Renal Cell Carcinoma – Single-Center Real-World Experience
by: Ivan Levakov, et al.
Published: (2024-01-01)

Aspects of a Methodological Approach to Determination of Interferon Alpha Specific Activity
by: M. L. Baykova, et al.
Published: (2020-03-01)

The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)

Identification of hub six interferon alpha response genes and immune cell infiltration characteristics in low-grade glioma
by: Xue Zhang, et al.
Published: (2025-07-01)

Chronic hepatitis b with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy
by: Sukran Kose, et al.
Published: (2011-07-01)

The value of interferon therapy for COVID-19 in children
by: L. N. Mazankova, et al.
Published: (2021-04-01)

On the Possibility of Using the Topical form of the Recombinant Interferon alpha-2b Drug in the Prevention of Acute Respiratory Viral Infections in Organized Groups
by: M. P. Kostinov, et al.
Published: (2024-05-01)

Interferon status at the women with recurrent genital herpes in combined liposomal RNA treatment
by: A. Sh. Makhmutkhodzhayev, et al.
Published: (2012-06-01)

The efficiency of interferon therapy for acute respiratory viral infections in young children
by: T. K. Chudakova, et al.
Published: (2020-03-01)

ACTIVATION OF SYNTHESIS OF ENDOGENOUS INTERFERON (REVIEW)
by: V. V. Poloskov, et al.
Published: (2019-01-01)

Clinical and epidemiologic efficacy of late interferon inductor in in the prevention of acute respiratory viral infections and influenza in 2017–2018 pre-epidemic period
by: V. A. Petrov, et al.
Published: (2021-06-01)

IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
by: Sophia Davidson, et al.
Published: (2016-08-01)

Present State of in vitro and in vivo Studies on Efficacy of Medical Nonspecific Protective Agents with Respect to Genotype IV Coronavirus Causing Severe Acute Respiratory Syndrome
by: V. N. Shchukina, et al.
Published: (2020-05-01)

Combination of nanosomal form of doxorubicin, interferon alpha, and nitroglycerin in the threatment of 101.8 glioblastoma in Wistar rats
by: V. V. Kudelkina, et al.
Published: (2022-01-01)

Interferon alpha-2b addition to intravitreal bevacizumab for diabetic macular edema: a randomized controlled trial
by: Saeed Karimi, et al.
Published: (2025-04-01)

The use of combined interferon alpha-2b-based medicine in the complex treatment of herpetic keratitis in patients after coronavirus infection
by: A. V. Surov, et al.
Published: (2023-07-01)

The established of a machine learning model for predicting the efficacy of adjuvant interferon alpha1b in patients with advanced melanoma
by: Linhan Jiang, et al.
Published: (2024-11-01)

Comparative assessment of the effectiveness and safety of an interferon inducer in the complex treatment of viral respiratory tract Infections in children aged 3-18 years in real-world practice during the 2023-2024 respiratory disease season
by: M. S. Savenkova, et al.
Published: (2024-12-01)

The use in pediatrics of recombinant interferon alfa-2b preparations in the dosage form rectal suppositories: whom? when? which ones?
by: M. S. Savenkova, et al.
Published: (2021-04-01)

Treatment of anicteric acute hepatitis C with peginterferon alpha-2a plus ribavirin
by: Delić Dragan, et al.
Published: (2005-01-01)

Keratopathy in Patients with Adenoviral Keratoconjunctivitis: Evaluation of the Effectiveness of Modern Interferon Preparations
by: E. A. Drozdova, et al.
Published: (2023-04-01)

Use of interferon in prevention and treatment of respiratory viral infections in adults and children
by: N. D. Yuschuk, et al.
Published: (2021-06-01)

Cytokine status indicators in children with acute respiratory viral infections after treatment with intranasal interferon-based medicine
by: O. I. Afanasyeva, et al.
Published: (2021-12-01)

EFFICACY AND SAFETY OF THE COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON ALFA-2A IN PATIENTS WITH CHRONIC HEPATITIS C: THE RESULTS OF TWO MULTICENTER, PROSPECTIVE, OPEN, NON-COMPARATIVE CLINICAL TRIALS
by: K. V. Zhdanov, et al.
Published: (2018-01-01)

MODERN OPPORTUNITIES OF INTERFERON THERAPY AT INFLUENZA AND ACUTE RESPIRATORY INFECTIONS IN CHILDREN
by: T. A. Chebotareva, et al.
Published: (2015-08-01)

Iron metabolism in chronic hepatitis C patients on antiviral treatment
by: K. V. Zhdanov, et al.
Published: (2014-09-01)